Baystate Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History

Baystate Wealth Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$3.82K	Hold
2023 Q3	$2.77K	Hold
2023 Q2	$3.42K	Hold
2023 Q1	$2.76K	Buy
2020 Q4	–	Sell
2020 Q3	$1K	Sell
2020 Q2	$11K	Buy